s6y
Company name or ticker
Search
Huber Reid M
4
BELLICUM PHARMACEUTICALS, INC: Statement of changes in beneficial ownership of securities
Filed
Thursday, January 6, 2022
Period
Jan 4, 2022
Accession number
0001628280-22-000416
Documents
FORM 4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header